600812.SS
600812.SS
CNE000000D16
NORTH CHINA PHARMACEUTICAL CO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
10.35B EUR
7.33B EUR
9.33B EUR
9.49B EUR
Enterprise Value
21.45B EUR
17.09B EUR
19.19B EUR
19.16B EUR
Valuation Multiples
Trailing P/E
86.14x
82.88x
74.06x
64.09x
Forward P/E
--
--
--
--
Price to Sales
1.26x
1.23x
1.41x
1.35x
Price to Book
1.88x
1.33x
1.68x
1.72x
EV/Revenue
2.62x
2.86x
2.9x
2.72x
EV/EBITDA
14.82x
37.51x
34.53x
31.31x
Price to FCF (P/FCF)
--
11.31x
15.5x
15.58x
EV/FCF
--
26.38x
31.86x
31.47x
FCF Yield
-0.92%
8.84%
6.45%
6.42%
ende